Home > Insider Trading > Filing (0001628280-25-011405)

Filing Details

Accession Number:: 0001628280-25-011405
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-07 17:40:05
Reporting Period:: 2025-03-05

Filing Date:: 2025-03-07
Accepted Time:: 2025-03-07 17:40:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Madrigal Pharmaceuticals Inc.	MDGL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1876996	E. Robert Waltermire	C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Senior Vp, Chief Pharma Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-05	6,825	$87.92	10,553	No	4	M	Direct
Common Stock	Acquisiton	2025-03-05	7,288	$87.09	17,841	No	4	M	Direct
Common Stock	Disposition	2025-03-05	900	$335.15	16,941	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,777	$336.78	15,164	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,146	$338.09	14,018	No	4	S	Direct
Common Stock	Disposition	2025-03-05	400	$339.68	13,618	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,657	$340.75	11,961	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,043	$341.84	10,918	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,077	$342.90	9,841	No	4	S	Direct
Common Stock	Disposition	2025-03-05	4,701	$343.85	5,140	No	4	S	Direct
Common Stock	Disposition	2025-03-05	1,412	$344.76	3,728	No	4	S	Direct
Common Stock	Acquisiton	2025-03-05	2,061	$0.00	5,789	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-03-05	6,825	$0.00	6,825	$87.92
Common Stock	Stock Option (Right to Buy)	Disposition	2025-03-05	7,288	$0.00	7,288	$87.09
Common Stock	Stock Option (Right to Buy)	Acquisiton	2025-03-05	1,157	$0.00	1,157	$347.28

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,375	2031-08-02	No	4	M	Direct
3,062	2032-02-22	No	4	M	Direct
1,157	2035-03-05	No	4	A	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.005 to $335.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.445 to $337.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.47 to $338.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.21 to $340.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.24 to $341.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.24 to $342.05, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.30 to $343.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $343.31 to $344.30, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.31 to $345.07, inclusive.
Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date.
All shares issued pursuant to the exercise of the options reported herein represent 6,825 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
All shares issued pursuant to the exercise of the options reported herein represent 7,288 shares underlying an overall option award of 12,250 shares. All exercised options had vested. As to the overall option for 12,250 shares, 25% of the shares underlying the option vested on February 24, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.